EKF Diagnostics Holdings Plc (EKF) - Product Pipeline Analysis, 2019 Update

Summary

EKF Diagnostics Holdings Plc (EKF Diagnostics) is an in vitro diagnostics company that designs, develops, manufactures, and markets point-of-care (POC) devices and tests; and central laboratory products. Its POC range includes hemoglobin analyzers, glucose analyzers and HbA1c analyzers that can be used for screening, monitoring and diagnosing patients, and conducting tests for common infectious diseases and pregnancy, while its central laboratory range includes various clinical reagents and centrifuges. EKF Diagnostics products find application in blood banks, general surgeries, pharmacies, hospitals, diabetes clinics, laboratories, and sports medicine. The company sells its products through OEM partnerships with large distributors, and through agreements with local distributors in various countries. EKF Diagnostics is headquartered in Cardiff, Wales, the UK.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company EKF Diagnostics Holdings Plc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company
 


EKF Diagnostics Holdings Plc Company Overview
EKF Diagnostics Holdings Plc Company Snapshot
EKF Diagnostics Holdings Plc Pipeline Products and Ongoing Clinical Trials Overview
EKF Diagnostics Holdings Plc – Pipeline Analysis Overview
Business Description
EKF Diagnostics Holdings Plc - Key Facts
EKF Diagnostics Holdings Plc - Major Products and Services
EKF Diagnostics Holdings Plc Pipeline Products by Development Stage
EKF Diagnostics Holdings Plc Ongoing Clinical Trials by Trial Status
EKF Diagnostics Holdings Plc Pipeline Products Overview
Altair 240
Altair 240 Product Overview
B-HB POC Analyser
B-HB POC Analyser Product Overview
BIOSEN HbA1c Instrument
BIOSEN HbA1c Instrument Product Overview
DiaSpect Tm
DiaSpect Tm Product Overview
FractalDx - Acute Transplant Rejection Diagnostic
FractalDx - Acute Transplant Rejection Diagnostic Product Overview
KidneyIntelX
KidneyIntelX Product Overview
KidneyIntelX Clinical Trial
Lactate Scout 4 - Clinic Use
Lactate Scout 4 - Clinic Use Product Overview
Point-Of-Care Test - Coagulation
Point-Of-Care Test - Coagulation Product Overview
Point-Of-Care Test - Vitamin D Test
Point-Of-Care Test - Vitamin D Test Product Overview
PointMan Assay - Breast Cancer
PointMan Assay - Breast Cancer Product Overview
PointMan Assay - Lung Cancer
PointMan Assay - Lung Cancer Product Overview
PointMan Assay - Skin Cancer
PointMan Assay - Skin Cancer Product Overview
PointMan PI3K DNA Enrichment Kit
PointMan PI3K DNA Enrichment Kit Product Overview
Quo-Lab - C-Reactive Protein
Quo-Lab - C-Reactive Protein Product Overview
RenaStat
RenaStat Product Overview
SensPoint
SensPoint Product Overview
Serum/Plasma Analyser
Serum/Plasma Analyser Product Overview
ß-Hydroxybutyrate LiquiColor Reagent
ß-Hydroxybutyrate LiquiColor Reagent Product Overview
Xtract Liquid Phase Extraction Device
Xtract Liquid Phase Extraction Device Product Overview
EKF Diagnostics Holdings Plc - Key Competitors
EKF Diagnostics Holdings Plc - Key Employees
EKF Diagnostics Holdings Plc - Key Employee Biographies
EKF Diagnostics Holdings Plc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
EKF Diagnostics Holdings Plc, Recent Developments
Jun 07, 2019: Study published in journal of clinical investigation insight demonstrates ability to predict early rejection in kidney transplant with FractalDx Portfolio Technology
Jun 04, 2019: Renalytix AI: Commercial scale manufacturing milestone for KidneyIntelX test materials
May 21, 2019: RenalytixAI expands core investigator group for kidney transplant advanced diagnostic programme
May 16, 2019: EKFs DiaSpect Tm hemoglobin analyzer supports anemia study in resource limited West Africa
May 08, 2019: Renalytix AI forms alliance to study KidneyIntelX in diabetes patients
May 02, 2019: FDA grants breakthrough device designation to KidneyIntelX
Apr 01, 2019: Study demonstrates machine learning can significantly improve prediction of rapid kidney function decline in patients with diabetes
Mar 25, 2019: Renalytix AI: Half-year report
Mar 22, 2019: RenalytixAI forms core investigator group for kidney transplant advanced diagnostic program
Mar 13, 2019: EKF Diagnostics Holdings: Final results
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
 


List Of Tables


EKF Diagnostics Holdings Plc Pipeline Products and Ongoing Clinical Trials Overview
EKF Diagnostics Holdings Plc Pipeline Products by Equipment Type
EKF Diagnostics Holdings Plc Pipeline Products by Indication
EKF Diagnostics Holdings Plc Ongoing Clinical Trials by Trial Status
EKF Diagnostics Holdings Plc, Key Facts
EKF Diagnostics Holdings Plc, Major Products and Services
EKF Diagnostics Holdings Plc Number of Pipeline Products by Development Stage
EKF Diagnostics Holdings Plc Pipeline Products Summary by Development Stage
EKF Diagnostics Holdings Plc Ongoing Clinical Trials by Trial Status
EKF Diagnostics Holdings Plc Ongoing Clinical Trials Summary
Altair 240 - Product Status
Altair 240 - Product Description
B-HB POC Analyser - Product Status
B-HB POC Analyser - Product Description
BIOSEN HbA1c Instrument - Product Status
BIOSEN HbA1c Instrument - Product Description
DiaSpect Tm - Product Status
DiaSpect Tm - Product Description
FractalDx - Acute Transplant Rejection Diagnostic - Product Status
FractalDx - Acute Transplant Rejection Diagnostic - Product Description
KidneyIntelX - Product Status
KidneyIntelX - Product Description
KidneyIntelX - A Clinical Validation Study of AI-enabled KidneyIntelX for Diagnosing Fast-Progressing Kidney Disease
KidneyIntelX - Prospective Clinical Utility Study of Kidneyintelx AI-enabled for the Diagnosis of Kidney Disease
Lactate Scout 4 - Clinic Use - Product Status
Lactate Scout 4 - Clinic Use - Product Description
Point-Of-Care Test - Coagulation - Product Status
Point-Of-Care Test - Coagulation - Product Description
Point-Of-Care Test - Vitamin D Test - Product Status
Point-Of-Care Test - Vitamin D Test - Product Description
PointMan Assay - Breast Cancer - Product Status
PointMan Assay - Breast Cancer - Product Description
PointMan Assay - Lung Cancer - Product Status
PointMan Assay - Lung Cancer - Product Description
PointMan Assay - Skin Cancer - Product Status
PointMan Assay - Skin Cancer - Product Description
PointMan PI3K DNA Enrichment Kit - Product Status
PointMan PI3K DNA Enrichment Kit - Product Description
Quo-Lab - C-Reactive Protein - Product Status
Quo-Lab - C-Reactive Protein - Product Description
RenaStat - Product Status
RenaStat - Product Description
SensPoint - Product Status
SensPoint - Product Description
Serum/Plasma Analyser - Product Status
Serum/Plasma Analyser - Product Description
ß-Hydroxybutyrate LiquiColor Reagent - Product Status
ß-Hydroxybutyrate LiquiColor Reagent - Product Description
Xtract Liquid Phase Extraction Device - Product Status
Xtract Liquid Phase Extraction Device - Product Description
EKF Diagnostics Holdings Plc, Key Employees
EKF Diagnostics Holdings Plc, Key Employee Biographies
EKF Diagnostics Holdings Plc, Other Locations
EKF Diagnostics Holdings Plc, Subsidiaries
Glossary
 


List Of Figures


EKF Diagnostics Holdings Plc Pipeline Products by Equipment Type
EKF Diagnostics Holdings Plc Pipeline Products by Development Stage
EKF Diagnostics Holdings Plc Ongoing Clinical Trials by Trial Status "
 


EKF Diagnostics Holdings Plc (EKF) - Product Pipeline Analysis, 2019 Update

EKF Diagnostics Holdings Plc (EKF) - Product Pipeline Analysis, 2019 Update market research report available in single user pdf license with Aarkstore Enterprise at USD 750

USD 750 View Report

EKF Diagnostics Holdings Plc (EKF) - Product Pipeline Analysis, 2018 Update

EKF Diagnostics Holdings Plc (EKF Diagnostics) is a medical device company that designs, develops, manufactures, and commercializes point-of-care (POC) devices and tests and chemical reagents used for manufacturing in central

USD 750 View Report

EKF Diagnostics Holdings Plc (EKF) - Product Pipeline Analysis, 2018 Update

EKF Diagnostics Holdings Plc (EKF Diagnostics) is a medical device company that designs, develops, manufactures, and commercializes point-of-care (POC) devices and tests and chemical reagents used for manufacturing in central

USD 750 View Report

EKF DIAGNOSTICS HOLDINGS PLC Company Profile - Business Operations, Strategies, SWOT Analysis and Financial Report

EKF DIAGNOSTICS HOLDINGS PLC Company Profile is a detailed strategic and analytical report on EKF DIAGNOSTICS HOLDINGS PLC. The 2018 version of the report offers detailed insights into the companys

USD 200 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available